ZA904338B - The use of naftpidil for the therapy of dysuria in cases of benign prostatic hypertrophy - Google Patents

The use of naftpidil for the therapy of dysuria in cases of benign prostatic hypertrophy

Info

Publication number
ZA904338B
ZA904338B ZA904338A ZA904338A ZA904338B ZA 904338 B ZA904338 B ZA 904338B ZA 904338 A ZA904338 A ZA 904338A ZA 904338 A ZA904338 A ZA 904338A ZA 904338 B ZA904338 B ZA 904338B
Authority
ZA
South Africa
Prior art keywords
dysuria
naftpidil
therapy
cases
benign prostatic
Prior art date
Application number
ZA904338A
Other languages
English (en)
Inventor
Gisbert Sponer
Sponer Gisbert
Ulrich Reicke
Reicke Ulrich
Michael Nelboeck-Hochstetter
Nelboeck-Hochstetter Michael
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6382247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA904338(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of ZA904338B publication Critical patent/ZA904338B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
ZA904338A 1989-06-07 1990-06-06 The use of naftpidil for the therapy of dysuria in cases of benign prostatic hypertrophy ZA904338B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918543A DE3918543A1 (de) 1989-06-07 1989-06-07 Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie

Publications (1)

Publication Number Publication Date
ZA904338B true ZA904338B (en) 1991-03-27

Family

ID=6382247

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904338A ZA904338B (en) 1989-06-07 1990-06-06 The use of naftpidil for the therapy of dysuria in cases of benign prostatic hypertrophy

Country Status (19)

Country Link
US (1) US5026706A (es)
EP (1) EP0401653B1 (es)
JP (1) JPH062673B2 (es)
KR (1) KR0131452B1 (es)
AT (1) ATE84416T1 (es)
AU (1) AU625766B2 (es)
CA (1) CA2017619C (es)
DD (1) DD294864A5 (es)
DE (2) DE3918543A1 (es)
DK (1) DK0401653T3 (es)
ES (1) ES2054147T3 (es)
GR (1) GR3007328T3 (es)
HK (1) HK46996A (es)
HU (1) HU206976B (es)
IE (1) IE62937B1 (es)
IL (1) IL94601A (es)
PH (1) PH26690A (es)
PT (1) PT94268B (es)
ZA (1) ZA904338B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
WO2001023405A2 (en) 1999-09-30 2001-04-05 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
BR102012000187A2 (pt) * 2012-01-05 2018-04-10 Univ Rio De Janeiro Derivados n-fenilpiperazínicos antagonistas de adrenoceptores a1a, a1d e de receptores 5-ht1a no tratamento da hiperplasia prostática benigna, composições farmacêuticas contendo os mesmos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.

Also Published As

Publication number Publication date
HUT54494A (en) 1991-03-28
HK46996A (en) 1996-03-22
EP0401653B1 (de) 1993-01-13
CA2017619C (en) 1995-06-20
HU206976B (en) 1993-03-01
US5026706A (en) 1991-06-25
IE62937B1 (en) 1995-03-08
AU625766B2 (en) 1992-07-16
GR3007328T3 (es) 1993-07-30
ES2054147T3 (es) 1994-08-01
DE59000748D1 (de) 1993-02-25
IL94601A0 (en) 1991-04-15
DK0401653T3 (da) 1993-03-29
DE3918543C2 (es) 1991-06-06
CA2017619A1 (en) 1990-12-07
HU903515D0 (en) 1990-10-28
JPH0324014A (ja) 1991-02-01
JPH062673B2 (ja) 1994-01-12
IL94601A (en) 1994-06-24
IE902014L (en) 1990-12-07
PH26690A (en) 1992-09-15
EP0401653A3 (de) 1991-07-17
AU5628290A (en) 1990-12-13
DE3918543A1 (de) 1990-12-13
DD294864A5 (de) 1991-10-17
ATE84416T1 (de) 1993-01-15
PT94268A (pt) 1991-02-08
KR910000152A (ko) 1991-01-29
KR0131452B1 (ko) 1998-04-17
PT94268B (pt) 1997-01-31
EP0401653A2 (de) 1990-12-12

Similar Documents

Publication Publication Date Title
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
SE8302774L (sv) Raffinerad, detoxifierad endotoxinprodukt samt sett att framstella detsamma jemte en terapeutisk komposition som innehaller produkten
EP0350846A3 (en) Condensed heterocyclic compounds and their use in therapy
DK0719558T3 (da) Ranolzin og beslægtede piperazin til anvendelse ved behandling af chocktilstande
AU6998787A (en) Transglutaminase inhibitors
HK51995A (en) Antimigraine alkxypyrimidine derivatives.
GB2100601B (en) An aromatase-inhibitor for use in a method of prophylaxis and/or of treatment by therapy of prostatic hyperplasia, and pharmaceutical preparations suitable for such a use.
ATE130589T1 (de) Verwendung von wässrigen kationischen kunststoffdispersionen zum imprägnieren und grundieren von saugfähigen substraten.
UA66793C2 (uk) Лептин як стримувач швидкого збільшення пухлини клітини
ZA904338B (en) The use of naftpidil for the therapy of dysuria in cases of benign prostatic hypertrophy
DK504389D0 (da) Adjuveret antigenoploesning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved
EP0350738A3 (de) (S)-Emopamil zur Anwendung bei der Behandlung von Migräne
DK437886A (da) Makrocycliske antibiotika samt deres fremstilling og anvendelse
ATE143808T1 (de) Proteintyrosinphosphatase alpha - inhibitoren zur tumorbehandlung
ZA877900B (en) Active compounds for preventing tumor metastases
ZA88922B (en) Use of oxoquinazoline derivatives in the treatment of hyperuricaemia
DE59103094D1 (de) Halterung für eine im Steckerkörper eines elektrischen Netzsteckers integrierte Ringkerndrossel.
ES8504793A1 (es) Un procedimiento para la preparacion de una quinazolina
IE892586L (en) Use of zofenopril for the treatment of rheumatoid arthritis
FR2517679B1 (es)
SE8900834D0 (sv) New uses of 4-(3-phosphono-2-propenyl)-2-piperazinecarboxylic acid
ES8706620A1 (es) Un procedimiento para preparar derivados de semicarbazida
IT1236140B (it) Dispositivo elettronico per la distribuzione d'informazioni